Best Peptides for Sleep in 2026
See what the research shows, who they're for, and how to access them.
Five peptides may improve your sleep: DSIP, sermorelin, epitalon, ipamorelin, and selank. Each targets a different mechanism, from boosting growth hormone release to restoring melatonin rhythms to calming GABA receptors.
Not all of these compounds are FDA approved. Sermorelin is the only one you can legally get by prescription today. The rest remain research compounds with limited human data. Here is what the evidence actually shows.
Peptides.io earns referral fees when readers book consultations or purchase products through our links. This is how we fund our editorial team and medical review process. Affiliate relationships do not influence our rankings, evidence grades, or editorial recommendations.
Quick comparison: peptides for sleep
| Peptide | Primary sleep mechanism | Evidence level | Legal status (US, 2026) | Estimated monthly cost |
|---|---|---|---|---|
| DSIP | Promotes delta (slow-wave) sleep | Limited human trials | Category 2 (not prescribable) | N/A (research only) |
| Sermorelin | Stimulates GH release during deep sleep | Moderate (human data) | Tier 1 (Rx, compoundable) | $150 to $300 |
| Ipamorelin | Stimulates GH release, improves sleep architecture | Limited (mostly clinical observation) | Category 2 (reclassification pending) | N/A (research only) |
| Epitalon | Restores melatonin production via pineal gland | Limited (small human studies) | Category 2 (not prescribable) | N/A (research only) |
| Selank | GABA modulation reduces anxiety before sleep | Limited (primarily Russian studies) | Category 2 (not prescribable) | N/A (research only) |
| Glycine | Lowers core body temperature, improves sleep onset | Strong (multiple human RCTs) | OTC amino acid supplement | $10 to $20 |
How peptides affect sleep
Peptides influence sleep through several distinct pathways. No single peptide works the same way as a traditional sleep medication like zolpidem or a benzodiazepine. Instead, peptides target the hormonal and neurochemical systems that regulate your natural sleep cycle.
Growth hormone secretagogues like sermorelin and ipamorelin increase growth hormone (GH) output from the pituitary gland. GH is released primarily during slow-wave sleep (stages 3 and 4). A 2004 review in Sleep Medicine Reviews by Obal and Krueger found that GHRH directly activates sleep-regulatory neurons in the hypothalamus. The result: longer stretches of deep, restorative sleep.
Other peptides work through different routes. DSIP (delta sleep-inducing peptide) targets brain regions involved in slow-wave sleep production. Epitalon stimulates melatonin synthesis in the pineal gland, helping reset circadian rhythm. Selank modulates GABA receptors, which may quiet the mental activity that keeps you awake.
The key difference from conventional sleep aids: these peptides do not force sedation. They support the biological processes your body already uses to fall and stay asleep.
DSIP (delta sleep-inducing peptide)
DSIP is a nine-amino-acid neuropeptide first isolated in 1974 by the Schoenenberger-Monnier research group from rabbit cerebral venous blood during induced sleep.
DSIP promotes delta-wave EEG activity, the electrical signature of the deepest phase of sleep. A 1981 trial with six volunteers found that intravenous DSIP reduced sleep onset time and increased overall sleep efficiency without causing sedation. A double-blind study published in Neuropsychobiology (1992) tested DSIP in 16 chronic insomnia patients over three nights. Sleep efficiency improved and sleep latency decreased compared to placebo, but the researchers concluded that the effects were statistically modest.
DSIP may also affect stress response. Some studies report that DSIP administration reduced cortisol levels in participants, which could explain part of its sleep-onset benefit.
FDA Status Notice DSIP is classified as a Category 2 bulk substance by the FDA. It cannot be legally compounded or prescribed in the United States under current enforcement guidelines. The FDA has cited potential immunogenicity concerns and a lack of adequate safety data. This content is provided for educational and research purposes only. peptides.io does not recommend purchasing or using this compound outside a supervised clinical setting.
Regulatory update (February 2026): HHS Secretary RFK Jr. announced that approximately 14 of 19 Category 2 peptides may return to Category 1 status. The official FDA reclassification list has not yet been published. Check peptides.io for updates.
Sermorelin
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). It stimulates the pituitary gland to release growth hormone naturally. Sermorelin is a Tier 1 compound, meaning it is legal to prescribe and compound in the United States with a valid prescription.
Sleep quality improvement is one of the most frequently reported benefits of sermorelin therapy. Research published in Sleep Medicine Reviews (Obal and Krueger, 2004) demonstrated that GHRH activates neurons in the preoptic hypothalamus. These neurons increase NREM sleep duration and slow-wave activity independent of GH release itself.
Clinical observations suggest sermorelin users experience reduced sleep latency (falling asleep 10 to 15 minutes faster), fewer nighttime awakenings, more time in deep sleep stages, and more vivid dreaming indicating improved REM architecture. These improvements typically appear within 1 to 3 weeks of consistent bedtime dosing.
Sermorelin is administered via subcutaneous injection, usually at bedtime. The typical dose ranges from 200 to 300 mcg per night. Monthly cost through a licensed compounding pharmacy runs $150 to $300.
Key takeaways
- Sermorelin is the only peptide on this list that is both legal to prescribe and supported by moderate human evidence for sleep improvement.
- Sleep benefits appear linked to GHRH’s direct effect on sleep-regulatory neurons, not just GH elevation.
- Bedtime dosing aligns with the body’s natural GH release window during early sleep.
How to access sermorelin for sleep
Sermorelin requires a prescription from a licensed physician. Several telehealth platforms offer virtual consultations and ship compounded sermorelin directly to your home.
| Provider | Insurance accepted | Subscription fee | Available peptides | Best for |
|---|---|---|---|---|
| Refills.com | No | Varies by program | Sermorelin, GLP-1, NAD+ | Broadest peptide selection |
| LifeMD | Select plans | From $75/month | Sermorelin, semaglutide | Insurance-covered weight loss |
| PlushCare | Most major plans | $16.99/month | Sermorelin (referral) | Patients with insurance |
peptides.io may earn a commission if you book a consultation through our links. This does not affect our editorial recommendations.
Ipamorelin
Ipamorelin is a selective growth hormone secretagogue that triggers GH release from the pituitary gland without significantly raising cortisol or prolactin. This selectivity makes ipamorelin one of the better-tolerated GH-releasing peptides.
Like sermorelin, ipamorelin may improve sleep quality by increasing the amount of time you spend in deep sleep stages. GH release peaks during slow-wave sleep, and stimulating that release at bedtime may reinforce the body’s natural sleep architecture. Clinical providers who prescribe ipamorelin commonly report that patients notice deeper sleep and improved morning alertness within 2 to 4 weeks.
The evidence base for ipamorelin’s sleep effects is primarily observational. No large-scale randomized controlled trials have tested ipamorelin specifically for sleep outcomes. Most data comes from clinical practice reports and mechanistic reasoning based on GH physiology.
FDA Status Notice Ipamorelin is classified as a Category 2 bulk substance by the FDA and cannot be legally compounded in the United States under current enforcement guidelines. This content is provided for educational and research purposes only. peptides.io does not recommend purchasing or using this compound outside a supervised clinical setting.
Regulatory update (February 2026): Ipamorelin is among the peptides expected to return to Category 1 status following HHS Secretary RFK Jr.’s February 27, 2026 announcement. The official FDA reclassification list has not yet been published.
Epitalon
Epitalon (also spelled epithalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the amino acid sequence of epithalamin, a bovine pineal gland extract. Epitalon is primarily studied for its effects on telomerase activation and melatonin production.
Epitalon’s connection to sleep runs through the pineal gland. A 2004 study published in Experimental Gerontology found that pineal peptides, including epitalon, restored age-related declines in melatonin production in both monkeys and elderly human subjects. Older adults with low nighttime melatonin showed restored melatonin output and more youthful circadian patterns after peptide administration.
A 2025 review in Molecules confirmed that epitalon upregulates key enzymes in melatonin biosynthesis within rat pinealocytes. The researchers described epitalon as a “molecular metronome” that may realign circadian gene expression.
Epitalon does not cause drowsiness. Instead, it appears to support the body’s natural melatonin cycle, which could benefit people whose sleep problems stem from circadian disruption, shift work, or age-related melatonin decline.
FDA Status Notice Epitalon is classified as a Category 2 bulk substance by the FDA. It is not approved for human use and cannot be legally compounded or prescribed in the United States. This content is provided for educational and research purposes only. peptides.io does not recommend purchasing or using this compound.
Regulatory update (February 2026): Epitalon is among the peptides expected to return to Category 1 status following the HHS announcement. The official FDA reclassification list is pending.
Selank
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed by the Russian Academy of Sciences. It is derived from tuftsin, a naturally occurring immunomodulatory peptide.
Selank may improve sleep indirectly by reducing the anxiety and mental racing that prevent sleep onset. A 2008 study published in the Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova tested selank in patients with generalized anxiety disorder. The researchers found anxiolytic effects comparable to benzodiazepine medications but without sedation or dependency risk.
The mechanism involves GABA receptor modulation. A 2016 study in Frontiers in Pharmacology showed that selank acts as a positive allosteric modulator of GABA-A receptors. Selank also influences serotonin and dopamine systems, which regulate mood and wakefulness balance.
One important distinction: selank does not directly promote sleep. It reduces the anxiety barrier to sleep onset. If your sleep problems stem from racing thoughts rather than a hormonal deficit, selank’s mechanism may be more relevant than GH-releasing peptides.
The evidence base is primarily from Russian research institutions. Independent international validation and long-term safety data remain limited.
FDA Status Notice Selank is not FDA approved for any indication in the United States. It cannot be legally prescribed or compounded under current enforcement guidelines. This content is provided for educational and research purposes only. peptides.io does not recommend purchasing or using this compound outside a supervised clinical setting.
Regulatory update (February 2026): Selank’s reclassification status is unclear. The HHS announcement focused on approximately 14 of 19 Category 2 peptides. Check peptides.io for updates as the official FDA list is published.
Glycine: the accessible alternative
Glycine is not a peptide therapy in the same sense as the compounds above. It is a simple amino acid available as an over-the-counter supplement. But glycine has stronger human evidence for sleep improvement than most prescription peptides on this list.
A randomized crossover trial published in Sleep and Biological Rhythms (Yamadera et al., 2007) found that 3 grams of glycine before bedtime reduced sleep onset time, improved sleep satisfaction, and increased sleep efficiency in 11 adults with persistent poor sleep. A follow-up study in Frontiers in Neurology (2012) confirmed that glycine reduces core body temperature via NMDA receptors in the suprachiasmatic nucleus, which signals the brain to initiate sleep.
Glycine does not disrupt normal sleep architecture. Participants in clinical trials reported less daytime fatigue and better memory performance the following day.
The standard research dose is 3 grams taken 30 to 60 minutes before bed. Glycine powder costs $10 to $20 per month. No prescription is needed.
Key takeaways
- Glycine has the strongest human clinical evidence of any compound on this list for sleep quality improvement.
- The effective dose (3 grams before bed) is well-established across multiple trials.
- Glycine is available without a prescription and costs a fraction of peptide therapy.
How to choose the right peptide for your sleep problem
Match the peptide to your specific sleep issue. Deep sleep deficiency, anxiety-driven insomnia, circadian disruption, and budget constraints each point to a different compound.
If you struggle with deep sleep and physical recovery: Sermorelin is the strongest candidate. It is the only Tier 1 (legally prescribable) peptide on this list with moderate evidence for increasing slow-wave sleep duration.
If your sleep problems stem from anxiety or racing thoughts: Selank’s GABA-modulating mechanism targets the mental barriers to sleep onset. But the evidence base is limited and the compound is not available by prescription in the US.
If your circadian rhythm is disrupted (shift work, jet lag, aging): Epitalon’s ability to restore melatonin production addresses the root cause. Human data is limited to small studies.
If you want the most evidence-backed, accessible option: Glycine. Multiple human RCTs support it, it costs under $20 per month, and you can buy it at any supplement store.
If you want a peptide that directly targets delta sleep: DSIP was designed for this purpose, but human evidence remains weak and the compound is not legally available.
FAQ
Do peptides for sleep work better than melatonin?
Peptides and melatonin work through different mechanisms. Melatonin supplements provide the hormone directly. Peptides like epitalon may stimulate your body to produce its own melatonin. GH-releasing peptides like sermorelin improve sleep architecture without affecting melatonin at all. For most people, melatonin or glycine is a reasonable first step before exploring peptide therapy.
Is DSIP legal in the United States?
DSIP is a Category 2 bulk substance under current FDA guidelines. It cannot be legally compounded or prescribed. The February 2026 HHS announcement suggests DSIP may return to Category 1 status, but the official reclassification list has not been published. Check peptides.io for regulatory updates.
Can sermorelin help with insomnia?
Sermorelin may improve sleep quality by increasing time spent in deep sleep stages and reducing sleep latency. Clinical observations report improvements within 1 to 3 weeks of bedtime dosing. Sermorelin is not FDA approved specifically for insomnia, but it is legally prescribable as a compounded medication for growth hormone optimization.
What is the safest peptide for sleep?
Glycine has the most established safety profile. It is a naturally occurring amino acid with no known serious side effects at the standard 3-gram dose. Among prescription peptides, sermorelin has the longest track record and is available through licensed providers. All Category 2 peptides carry unknown long-term risk profiles.
How long do peptides take to improve sleep?
Sermorelin users typically report sleep improvements within 1 to 3 weeks. Glycine works on the first night for many people. Epitalon’s melatonin-restoring effects may take several weeks of consistent use. DSIP’s effects in clinical trials appeared within the first few nights of administration.
Do I need a prescription for sleep peptides?
Sermorelin requires a prescription from a licensed physician and is available through telehealth platforms. Glycine is an OTC supplement with no prescription needed. DSIP, epitalon, ipamorelin, and selank are Category 2 substances that cannot currently be prescribed in the US. If reclassification occurs, some of these may become prescribable through compounding pharmacies.
Can peptides replace my current sleep medication?
Peptides are not a substitute for prescription sleep medications without your doctor’s guidance. If you take a benzodiazepine, Z-drug, or other sleep medication, talk to your prescribing physician before making any changes. Peptides like sermorelin or glycine may complement your existing routine, but they should not replace medically supervised treatment.
Are there side effects from sleep peptides?
Sermorelin side effects may include injection site reactions, flushing, and headache. Glycine is well tolerated at 3 grams per day with no significant reported side effects. DSIP’s safety profile is poorly characterized due to limited human data. The FDA has flagged potential immunogenicity concerns. Selank appears well tolerated in clinical studies, but long-term safety data is lacking.
The bottom line
Sermorelin is the most practical peptide option for sleep improvement in 2026. It is legal, prescribable, and backed by moderate evidence linking GHRH to deeper slow-wave sleep. Glycine offers the strongest clinical evidence overall and costs a fraction of any peptide therapy. DSIP, epitalon, and ipamorelin show promise in early research, but all three are Category 2 substances with limited human data and no current legal path to prescription in the US.
Talk to a licensed healthcare provider before starting any peptide therapy. Your sleep problem may have causes that a peptide alone will not address.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any new treatment or medication.